Page 572 - Williams Hematology ( PDFDrive )

546 Part VI: The Erythrocyte Chapter 36: Pure Red Cell Aplasia 547

106. Peschle C, Marmont AM, Marone G, et al: Pure red cell aplasia: Studies on an IgG 139. Akard LP, Brandt J, Lu L, et al: Chronic T cell lymphoproliferative disorder and pure red
serum inhibitor neutralizing erythropoietin. Br J Haematol 30(4):411, 1975. cell aplasia. Further characterization of cell-mediated inhibition of erythropoiesis and
107. Casadevall N, Dupuy E, Molho-Sabatier P, et al: Autoantibodies against erythropoietin clinical response to cytotoxic chemotherapy. Am J Med 83(6):1069, 1987.
in a patient with pure red-cell aplasia. N Engl J Med 334(10):630, 1996. 140. Reid TJ 3rd, Mullaney M, Burrell LM, et al: Pure red cell aplasia after chemotherapy for
108. Prabhakar SS, Muhlfelder T: Antibodies to recombinant human erythropoietin causing Hodgkin’s lymphoma: In vitro evidence for T cell mediated suppression of erythropoie-
pure red cell aplasia. Clin Nephrol 47(5):331, 1997. sis and response to sequential cyclosporin and erythropoietin. Am J Hematol 46(1):48,
109. Casadevall N, Nataf J, Viron B, et al: Pure red-cell aplasia and antierythropoietin anti- 1994.
bodies in patients treated with recombinant erythropoietin. N Engl J Med 346(7):469, 141. Socinski MA, Ershler WB, Tosato G, et al: Pure red blood cell aplasia associated with
2002. chronic Epstein-Barr virus infection: Evidence for T cell-mediated suppression of ery-
110. Locatelli F and Del Vecchio L. Pure red cell aplasia secondary to treatment with ery- throid colony forming units. J Lab Clin Med 104(6):995, 1984.
thropoietin. J Nephrol 16(4):461, 2003. 142. Levitt LJ, Reyes GR, Moonka DK, et al: Human T cell leukemia virus-I-associated
111. Pollock C, Johnson DW, Horl WH, et al: Pure red cell aplasia induced by erythropoie- T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and
sis-stimulating agents. Clin J Am Soc Nephrol 3(1):193, 2008. chronic T gamma-lymphoproliferative disease. J Clin Invest 81(2):538, 1988.
112. McKoy JM, Stonecash RE, Cournoyer D, et al: Epoetin-associated pure red cell aplasia: 143. Fisch P, Handgretinger R, Schaefer HE: Pure red cell aplasia. Br J Haematol 111(4):1010,
Past, present, and future considerations. Transfusion 48(8):1754, 2008. 2000.
113. Barger TE, Wrona D, Goletz TJ, et al: A detailed examination of the antibody prevalence 144. Lipton JM, Nadler LM, Canellos GP, et al: Evidence for genetic restriction in the sup-
and characteristics of anti-ESA antibodies. Nephrol Dial Transplant 27(10):3892, 2012. pression of erythropoiesis by a unique subset of T lymphocytes in man. J Clin Invest
114. Fijal B, Ricci D, Vercammen E, et al: Case-control study of the association between 72(2):694, 1983.
select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia. Phar- 145. Kurtzman GJ, Cohen BJ, Field AM, et al: Immune response to B19 parvovirus and an
macogenomics 9(2):157, 2008. antibody defect in persistent viral infection. J Clin Invest 84(4):1114, 1989.
115. Bolan CD, Leitman SF, Griffith LM, et al: Delayed donor red cell chimerism and pure 146. Geetha D, Zachary JB, Baldado HM, et al: Pure red cell aplasia caused by Parvovirus
red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic B19 infection in solid organ transplant recipients: A case report and review of literature.
stem cell transplantation. Blood 98(6):1687, 2001. Clin Transplant 14(6):586, 2000.
116. Grigg AP, Juneja SK: Pure red cell aplasia with the onset of graft versus host disease. 147. Frickhofen N, Abkowitz JL, Safford M, et al: Persistent B19 parvovirus infection in
Bone Marrow Transplant 32(11):1099, 2003. patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable
117. Hayden PJ, Gardiner N, Molloy K, et al: Pure red cell aplasia after a major ABO- cause of anemia in AIDS. Ann Intern Med 113(12):926, 1990.
mismatched bone marrow transplant for chronic myeloid leukaemia: Response to 148. Wiktor-Jedrzejczak W, Szczylik C, Gonas P, et al: Different marrow cell number
re-introduction of cyclosporin. Bone Marrow Transplant 33(4):459, 2004. requirements for the haemopoietic colony formation and the curve of the W/Wv ane-
118. Helbig G, Stella-Holowiecka B, Wojnar J, et al: Pure red-cell aplasia following major mia. Experientia 35(4):546, 1979.
and bi-directional ABO-incompatible allogeneic stem-cell transplantation: Recovery 149. Abkowitz JL, Brown KE, Wood RW, et al: Clinical relevance of parvovirus B19 as a
of donor-derived erythropoiesis after long-term treatment using different therapeutic cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis
strategies. Ann Hematol 86(9):677, 2007. 176(1):269, 1997.
119. Charles RJ, Sabo KM, Kidd PG, et al: The pathophysiology of pure red cell aplasia: 150. Mylonakis E, Dickinson BP, Mileno MD, et al: Persistent parvovirus B19 related ane-
Implications for therapy. Blood 87(11):4831, 1996. mia of seven years’ duration in an HIV-infected patient: Complete remission associated
120. Chikkappa G, Zarrabi MH, Tsan MF: Pure red-cell aplasia in patients with chronic with highly active antiretroviral therapy. Am J Hematol 60(2):164, 1999.
lymphocytic leukemia. Medicine (Baltimore) 65(5):339, 1986. 151. Morelli P, Bestetti G, Longhi E, et al: Persistent parvovirus B19-induced anemia in an
121. Visco C, Barcellini W, Maura F, et al: Autoimmune cytopenias in chronic lymphocytic HIV-infected patient under HAART. Case report and review of literature. Eur J Clin
leukemia. Am J Hematol 2014. Microbiol Infect Dis 26(11):833, 2007.
122. Go RS, Lust JA, Phyliky RL: Aplastic anemia and pure red cell aplasia associated with 152. Garcia-Suarez J, Pascual T, Munoz MA, et al: Myelodysplastic syndrome with erythroid
large granular lymphocyte leukemia. Semin Hematol 40(3):196, 2003. hypoplasia/aplasia: A case report and review of the literature. Am J Hematol 58(4):319,
123. Lacy MQ, Kurtin PJ, Tefferi A: Pure red cell aplasia: Association with large granular 1998.
lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 153. Hirai H: Molecular pathogenesis of MDS. Int J Hematol 76(Suppl 2):213, 2002.
87(7):3000, 1996. 154. Pellagatti A, Esoof N, Watkins F, et al: Gene expression profiling in the myelodysplastic
124. Yamada O: Clonal T cell proliferation in patients with pure red cell aplasia. Leuk Lym- syndromes using cDNA microarray technology. Br J Haematol 125(5):576, 2004.
phoma 35(1-2):69, 1999. 155. Darley RL, Hoy TG, Baines P, et al: Mutant N-RAS induces erythroid lineage dysplasia
125. Fujishima N, Hirokawa M, Fujishima M, et al: Oligoclonal T cell expansion in blood in human CD34+ cells. J Exp Med 185(7):1337, 1997.
but not in the thymus from a patient with thymoma-associated pure red cell aplasia. 156. Vlachos A, Farrar JE, Atsidaftos E, et al: Diminutive somatic deletions in the 5q region
Haematologica 91(12 Suppl):ECR47, 2006. lead to a phenotype atypical of classical 5q− syndrome. Blood 122(14):2487, 2013.
126. Koskela HL, Eldfors S, Ellonen P, et al: Somatic STAT3 mutations in large granular 157. DeZern AE, Pu J, McDevitt MA, et al: Burst-forming unit–erythroid assays to distin-
lymphocytic leukemia. N Engl J Med 366(20):1905, 2012. guish cellular bone marrow failure disorders. Exp Hematol 41(9):808, 2013.
127. Qiu ZY, Fan L, Wang L, et al: STAT3 mutations are frequent in T-cell large granular 158. Lacombe C, Casadevall N, Muller O, et al: Erythroid progenitors in adult chronic pure
lymphocytic leukemia with pure red cell aplasia. J Hematol Oncol 6:82, 2013. red cell aplasia: Relationship of in vitro erythroid colonies to therapeutic response.
128. Ghrenassia E, Roulin L, Aline-Fardin A, et al: The spectrum of chronic CD8+ T-cell Blood 64(1):71, 1984.
expansions: Clinical features in 14 patients. PLoS One 9(3):e91505, 2014. 159. Mangan KF, Shadduck RK: Successful treatment of chronic refractory pure red cell
129. Ishida F, Matsuda K, Sekiguchi N, et al: STAT3 gene mutations and their association aplasia with antithymocyte globulin: Correlation with in vitro erythroid culture studies.
with pure red cell aplasia in large granular lymphocyte leukemia. Cancer Sci 105(3):342, Am J Hematol 17(4):417, 1984.
2014. 160. Shelly S, Agmon-Levin N, Altman A, et al: Thymoma and autoimmunity. Cell Mol
130. Abkowitz JL, Powell JS, Nakamura JM, et al: Pure red cell aplasia: Response to therapy Immunol 8(3):199, 2011.
with anti-thymocyte globulin. Am J Hematol 23(4):363, 1986. 161. Oski FA: Hematologic consequences of chloramphenicol therapy. J Pediatr 94(3):515,
131. Abkowitz JL, Kadin ME, Powell JS, et al: Pure red cell aplasia: Lymphocyte inhibition of 1979.
erythropoiesis. Br J Haematol 63(1):59, 1986. 162. Holbro A, Jauch A, Lardinois D, et al: High prevalence of infections and autoimmunity
132. Hanada T, Abe T, Nakamura H, et al: Pure red cell aplasia: Relationship between inhib- in patients with thymoma. Hum Immunol 73(3):287, 2012.
itory activity of T cells to CFU-E and erythropoiesis. Br J Haematol 58(1):107, 1984. 163. Hirst E, Robertson TI: The syndrome of thymoma and erythroblastopenic anemia. A
133. Mangan KF, D’Alessandro L: Hypoplastic anemia in B cell chronic lymphocytic leu- review of 56 cases including 3 case reports. Medicine (Baltimore) 46(3):225, 1967.
kemia: Evolution of T cell-mediated suppression of erythropoiesis in early-stage and 164. Sawada K, Fujishima N, Hirokawa M: Acquired pure red cell aplasia: Updated review of
late-stage disease. Blood 66(3):533, 1985. treatment. Br J Haematol 142(4):505, 2008.
134. Mangan KF, Chikkappa G, Farley PC: T gamma (T gamma) cells suppress growth of 165. Firkin FC, Maher D: Cytotoxic immunosuppressive drug treatment strategy in pure red
erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic cell aplasia. Eur J Haematol 41(3):212, 1988.
lymphocytic leukemia. J Clin Invest 70(6):1148, 1982. 166. Kwong YL, Wong KF, Liang RH, et al: Pure red cell aplasia: Clinical features and treat-
135. Hoffman R, Kopel S, Hsu SD, et al: T cell chronic lymphocytic leukemia: Presence in ment results in 16 cases. Ann Hematol 72(3):137, 1996.
bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood 167. Mamiya S, Itoh T, Miura AB: Acquired pure red cell aplasia in Japan. Eur J Haematol
52(1):255, 1978. 59(4):199, 1997.
136. Nagasawa T, Abe T, Nakagawa T: Pure red cell aplasia and hypogammaglobulinemia 168. Yamada O, Motoji T, Mizoguchi H: Selective effect of cyclosporine monotherapy for
associated with Tr-cell chronic lymphocytic leukemia. Blood 57(6):1025, 1981. pure red cell aplasia not associated with granular lymphocyte-proliferative disorders.
137. Handgretinger R, Geiselhart A, Moris A, et al: Pure red-cell aplasia associated with Br J Haematol 106(2):371, 1999.
clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N 169. Raghavachar A: Pure red cell aplasia: Review of treatment and proposal for a treatment
Engl J Med 340(4):278, 1999. strategy. Blut 61(2-3):47, 1990.
138. Mangan KF, Volkin R, Winkelstein A: Autoreactive erythroid progenitor-T suppressor 170. Totterman TH, Hoglund M, Bengtsson M, et al: Treatment of pure red-cell aplasia and
cells in the pure red cell aplasia associated with thymoma and panhypogammaglobu- aplastic anaemia with ciclosporin: Long-term clinical effects. Eur J Haematol 42(2):126,
linemia. Am J Hematol 23(2):167, 1986. 1989.

Kaushansky_chapter 36_p0539-0548.indd 547 9/17/15 6:15 PM